期刊文献+

血清Cystatin C与乙型肝炎的关系 被引量:1

Relationship between cystatin C and severity of hepatitis B
下载PDF
导出
摘要 目的探讨血清半胱氨酸蛋白酶抑制剂C(Cystatin C)与乙型肝炎的关系。方法用颗粒增强透射免疫比浊法检测97例乙型肝炎患者及25例健康志愿者的血清Cystatin C水平,同时测其血清HBV-DNA(定量)、ALT、AST、TBIL、PT以及透明质酸(HA)、III型前胶原(PIIIP)、IV型胶原(CL-IV)、层粘连蛋白(LN)等。分析血清Cystatin C与临床类型及HBV-DNA、HBV-M、肝纤维化血清学指标间的关系。结果血清Cystatin C水平在不同临床类型的乙型肝炎间差异无统计学意义;Cystatin C与HBV-DNA(定量)、ALT、AST、TBIL、PT以及血清纤维化指标等不相关。结论血清Cystatin C与乙型肝炎的临床类型不相关。 Objective To explore the relationship between Serum cystatin C and hepatitis B.Methods The concentrations of serum cystatin C in 97 patients with hepatitis B were assayed by icropartical enhanced turbid-imetry and compared with those in 25 healthy persons as control group.Serum HBV-DNA(quantitative),alanine aminotransferase(ALT),aspartate aminotransferase(AST),total bilirubin(TBIL),prothrombin time(PT),hyaluro-nic acid(HA),Ⅲ procollagen type(PⅢP),Ⅳ-type collagen(CL-Ⅳ)and laminin(LN)were assayed at the same time.Results There were no significant differences in cystatin C concentrations among the different clinical types of hepatitis B;cystatin C didn't correlate with HBV-DNA,ALT,AST,TBIL or PT;any significant correlation was not found between cystatin C and serum fibrosis indicators.Conclusion There are no significant correlation between cystatin C and the clinical types of hepatitis B.
机构地区 宁波市肝病医院
出处 《现代实用医学》 2009年第7期693-695,F0002,共4页 Modern Practical Medicine
基金 宁波市科技局 宁波市卫生局基金 编号200539
关键词 肝炎 乙型 肝硬化 半胱氨酸蛋白酶抑制剂 Hepatitis B Liver cirrhosis Cysteine proteinase inhibitors
  • 相关文献

参考文献11

  • 1Tetsuo Hayashi, Kosaku Nitta, Keiko Uchida, et al. Clinical assessment of serum cystatin c as a marker ofglomerular filtration rate in patients with various renal diseases[J]. Clin Exp Nephrol, 2000, (4) : 133-136.
  • 2Chantrel F, Agin A, Offner M, et al. Comparison of cystatin c versus creatinine for detection of mild renal failure[J]. Clin Nephrol, 2000, 54(5) : 374.
  • 3纪斌,黄群,万腊根,陈富明,王健,朱勇,陈钦开,吕农华,应豪.血清Cystatin C测定在亚临床肝肾综合征诊断中的价值[J].肝脏,2006,11(5):325-326. 被引量:1
  • 4中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14012
  • 5Filer G, Prien F, Volhner I, et al. Diagnostic sensitivity of serum cystatin c for impaired glomerular filtration rate[J]. Pediatr Nephrol, 1999, 13(6) : 501-505.
  • 6Rander E, Erlandsen EJ. Serum cystatin c as an endogenous marker of the rerlal function: a review[J]. Clin Chem LabMed, 1999, 37(4) : 389-395.
  • 7Ylinen EA, Ala-houhala M, Harmoinen AP, et al. Cystatin c as an marker of glomerular filtration rate in pediatric patients[J]. Pediatr Nephrol,1999,13(6):506-509.
  • 8Cha S-C, Wang C,P, Chang Y-H, et al. Increased cystatin C serum concentration in patients with hepatic disease of various severities. Clin Chim Acta, 2004, 347(1-2 ):133-138.
  • 9Takeuchi M, Fukuda Y, Nakano I, Katano Y, Hayakawa T. Elevation of serum cystatin C concentration in patients with chronic liver disease. Eur J Gastroenterol Hepatol, 2001,13( ): 951-955.
  • 10林炜炜,徐晓萍,于嘉屏.血清胱氨酸蛋白酶抑制剂C浓度在肝脏疾病中的变化和意义[J].现代检验医学杂志,2007,22(6):81-82. 被引量:9

二级参考文献9

  • 1蔡钢强,垢敬,焦连亭.胱抑素C的生物学特性及临床应用评价[J].国际检验医学杂志,2006,27(5):457-460. 被引量:57
  • 2Orlando R,Mussap M,Plebani M,et al.Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis.Clin Chem,2002,48:850-858.
  • 3Hayashi H,Nitta K,Uchida K,et al.Clinical assessment of serum cystatin c as a marker of glomerular filtration rate in patients with various renal diseases.Clin Exp Nephrol,2000,4:133-136.
  • 4Chantrel F,Agin A,Offner M,et al.Comparison of cystatin c versus creatinine for detection of mild renal failure.Clin Nephrol,2000,54:374.
  • 5Lebensztejn DM,Skiba E,Kaczmarski M,et al.Serum cystatin C concentration does not predict advanced liver disease in children with chronic hepatitis B.Clinica Chimica Acta,2004,347:227-228.
  • 6Gerbes AL,Gülberg V,Bilzer M,et al.Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver.Gut,2002,50:106-110.
  • 7Kos J,Stabuc B,Schweiger A,et al. Cathepsins B,H and L and their inhibitors stefin A and cystatin C in sera of melanoma patients[J]. Clin Cancer Res, 1997, 3(6) : 1815-1822.
  • 8Walsh KM,Timms P,Campbell S,et al. Plasma activities of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases-1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C:comparlson using ROC analysis [J]. Dig Dis Sci, 1999,44 (4): 624- 630.
  • 9Shu-Chen Chu, Chi-Ping Wang, Yin-Hsin Chang,et al. Increased cystatin C serum concentrations in patients with hepatic diseases of various severities [J]. Clin Chim Acta , 2004 , 34 7 (1) :133-138.

共引文献14019

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部